LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 30.64 | 17.25 | 2464 | 1887 | 1.3055 | 1.0803 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 32.61 | 17.25 | 25 | 2136 | 0.0117 | 0.0548 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 32.61 | 17.25 | 2060 | 2136 | 0.9643 | 0.9896 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 32.61 | 17.25 | 1 | 2136 | 0.0005 | -0.3361 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 32.61 | 17.25 | 2708 | 2136 | 1.2676 | 1.0694 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 34.57 | 17.25 | 13 | 2523 | 0.0052 | -0.0386 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 34.57 | 17.25 | 2237 | 2523 | 0.8866 | 0.9668 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 34.57 | 17.25 | 1 | 2523 | 0.0004 | -0.3270 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 34.57 | 17.25 | 2932 | 2523 | 1.1620 | 1.0422 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 36.54 | 17.25 | 4 | 2679 | 0.0015 | -0.1819 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 36.54 | 17.25 | 2403 | 2679 | 0.8967 | 0.9703 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 36.54 | 17.25 | 2 | 2679 | 0.0007 | -0.2562 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 36.54 | 17.25 | 3215 | 2679 | 1.1997 | 1.0507 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 38.51 | 17.25 | 28 | 2906 | 0.0096 | 0.0677 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 38.51 | 17.25 | 2615 | 2906 | 0.8998 | 0.9717 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 38.51 | 17.25 | 1 | 2906 | 0.0003 | -0.3196 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 38.51 | 17.25 | 3525 | 2906 | 1.2130 | 1.0529 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 40.48 | 17.25 | 35 | 3125 | 0.0112 | 0.0989 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 40.48 | 17.25 | 2877 | 3125 | 0.9204 | 0.9780 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 40.48 | 17.25 | 2 | 3125 | 0.0006 | -0.2497 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 40.48 | 17.25 | 3797 | 3125 | 1.2147 | 1.0525 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 42.45 | 17.25 | 33 | 3504 | 0.0094 | 0.0883 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 42.45 | 17.25 | 3055 | 3504 | 0.8718 | 0.9645 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 42.45 | 17.25 | 2 | 3504 | 0.0006 | -0.2450 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 42.45 | 17.25 | 4106 | 3504 | 1.1718 | 1.0418 | MN20160310_N02 | J17 |